Fig. 3

Clinical efficacy. a Swimmer plot of 46 patients who reached the primary endpoint in this trial. b Representative radiographic image, endoscopic, specimen, and pathological image in patients of TRG 0 and 3. The white arrows represent the lesion sites. c Waterfall plot of maximum percent change in tumor size from baseline as measured according to RECIST v1.1. d Changes of pre-treatment cT and cN stage to post-treatment ypT and ypN stage in 46 patients who reached the primary endpoint. e Dynamic alteration of folate receptor-positive circulating tumor cells (FR+ CTCs) levels at pre-neoadjuvant (Pre) and before surgery (Post). The median and interquartile range are shown for each group